Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.68 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | HTT | P42858 | 3/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10735111 | 0.90 | MEN1 (0.81) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL29054812 | 0.89 | MEN1 (0.58) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL29375096 | 0.88 | MEN1 (0.78) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL93420 | 0.88 | MEN1 (0.78) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL10354488 | 0.86 | MEN1 (0.75) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL13885068 | 0.85 | KMT2A (0.54) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL2128469 | 0.83 | MEN1 (0.76) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL3029820 | 0.82 | KCNMA1 (0.53) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL2989871 | 0.82 | HPGD (0.47) | MEN1KMT2AGAAUSP2KEAP1 | |
| SCHEMBL16993471 | 0.82 | MEN1 (0.59) | MEN1KMT2AGAAUSP2KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116622665-A | Method for generating O-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | claimed |
| CN-116622664-B | Method for generating C-glycoside through biocatalysis | 湖南师范大学 | 2026-01-23 | — | — | CN | disclosed |
| CN-116622665-A | Method for generating O-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116622665-A | Method for generating O-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116622664-A | Method for generating C-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116622664-A | Method for generating C-glycoside through biocatalysis | 湖南师范大学 | 2023-08-22 | — | — | CN | disclosed |
| US-20220362276-A1 | Small Molecule Inhibitors of Viral Replication | THE TRUSTEES OF PRINCETON UNIVERSITY | 2022-11-17 | — | — | US | disclosed |
| WO-2020231979-A9 | SMALL MOLECULE INHIBITORS OF VIRAL REPLICATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2021-06-17 | — | — | WO | disclosed |
| WO-2020231979-A1 | SMALL MOLECULE INHIBITORS OF VIRAL REPLICATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-0112587-B1 | DERIVATIVES OF 4-(1-(PHENYL)-1-(HYDROXY)-PROP-1-YL)-RESORCINE, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1990-09-19 | — | — | EP | disclosed |
| US-4510338-A | TREATMENT OF ACUTE ETHANOLIC INTOXICATION/- | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1985-04-09 | — | — | US | disclosed |
| EP-0112587-A2 | Derivatives of 4-(1-(phenyl)-1-(hydroxy)-prop-1-yl)-resorcine, process for their preparation and medicines containing these compounds | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1984-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220362276-A1 | Small Molecule Inhibitors of Viral Replication | HSPH1, HSP90AB1, HSP90AA1 | MEN1 4192/4885KMT2A 3931/4885GAA 733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.